RE: JP Jenkins2 Apr 2025 18:28
On the REDX website News & Events section - dated 01 April 2025; No idea what happens after that!
REDX PHARMA LIMITED
("Redx" or the “Company")
Redx Pharma concludes trading on JP Jenkins as of 1 May 2025
Alderley Park, UK, 1 April 2025 Redx Pharma (JPJ:REDX), the clinical-stage,
biotechnology company focussed on developing novel, small molecule, targeted
therapeutics for fibrotic disease, announces the discontinuation of trade on JP
Jenkins, with the final day of trade being 30 April 2025.
Redx Pharma arranged for a matched bargain facility to be provided through JP
Jenkins on 1 May 2024, after delisting from AIM and under a one year contract
which is now complete. The company’s ordinary shares were admitted under the
ticker: REDX.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in
companies, enabling shareholders and prospective investors to buy and sell equity
on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and
Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative price and transaction history are available on J P Jenkins’s website at:
www.jpjenkins.com until 30 April 2025